Hôpital universitaire Robert-Debré Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02504619
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

APHP- Hôpital Robert Debré | Hopital Universitaire Robert-Debre | Robert Debre, Paris, France

Active Ingredients

Drugs in Phase 2 Trials (3)

codeine (Phenergan) (1 trial)

hydroxyurea (hydrea) (1 trial)

oxybutynin (ditropan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 2)

Hemoglobinopathies (Phase 2)

Thalassemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3